Team:Oxford/P&P public engagement
From 2014.igem.org
(Difference between revisions)
(7 intermediate revisions not shown) | |||
Line 228: | Line 228: | ||
<div class="grey_news_block"> | <div class="grey_news_block"> | ||
- | There is some concern that patenting could lead to creation of commercial monopolies and inhibit research | + | There is some concern that patenting could lead to creation of commercial monopolies and inhibit research (e.g. BRCA 1 Gene monopoly causing increase in price of testing which could potentially save lives). |
</div> | </div> | ||
Line 274: | Line 274: | ||
</div> | </div> | ||
</div> | </div> | ||
- | + | <br> | |
We moved on to discuss ways in which these concerns could be allayed and advanced in order to allow the advance of synthetic biology with cross community support. The most important of the factors raised are explored below... | We moved on to discuss ways in which these concerns could be allayed and advanced in order to allow the advance of synthetic biology with cross community support. The most important of the factors raised are explored below... | ||
- | + | <br> | |
Line 290: | Line 290: | ||
<div class="grey_news_block"> | <div class="grey_news_block"> | ||
- | All members of the group agreed that scientists should. Some members also expressed scepticism as to the claims of synthetic biology, and suspected that the potential benefits of the technology had been 'overhyped' in many areas, creating unrealistic hopes. It is important | + | All members of the group agreed that scientists should. Some members also expressed scepticism as to the claims of synthetic biology, and suspected that the potential benefits of the technology had been 'overhyped' in many areas, creating unrealistic hopes. It is important that the scientific and political communities listen, and are seen to be listening, to the concerns of the public so that they feel actively involved in the development of synbio solutions and their integration into everyday life and society. |
</div> | </div> | ||
Line 697: | Line 697: | ||
<!-- END TIMELINE WHITEBOX HERE --> | <!-- END TIMELINE WHITEBOX HERE --> | ||
- | <br><br> | + | <br><br></div> |
+ | <a href="https://static.igem.org/mediawiki/2014/3/39/OxiGEM_Public_Survey.pdf"> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/6/6e/Get_Involved_Public_Opinion_Top.jpg" style="float:left;position:relative; width:95%; margin-right:2.5%;margin-left:2.5%;" /></a> | ||
+ | <a href="https://static.igem.org/mediawiki/2014/4/40/OxiGEM_Public_Survey.txt"> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/3/35/Get_Involved_IP_Survey_Bottom.jpg" style="float:left;position:relative; width:95%; margin-right:2.5%;margin-left:2.5%;" /></a> | ||
+ | <br> | ||
+ | Oxford iGEM 2014 | ||
- | |||
- | |||
- | |||
</div> | </div> | ||
Line 710: | Line 713: | ||
Inspired by the results of the focus groups and survey we organised and developed activities to bring the world of synthetic biology to members of the public. Click here check out more on our <a href="https://2014.igem.org/Team:Oxford/Events"> Events</a> page! | Inspired by the results of the focus groups and survey we organised and developed activities to bring the world of synthetic biology to members of the public. Click here check out more on our <a href="https://2014.igem.org/Team:Oxford/Events"> Events</a> page! | ||
<img src="https://static.igem.org/mediawiki/2014/f/fa/Oxford_Public_engagement_events.png | <img src="https://static.igem.org/mediawiki/2014/f/fa/Oxford_Public_engagement_events.png | ||
- | " style="float:left;position:relative; width:100%;" /> | + | " style="float:left;position:relative; width:100%;" />. |
<br> | <br> | ||
- | + | We hope to excite a people from across society about the possibilities of synthetic biology, and to engage people in the debate as to how the science can become accepted into our everyday lives. We were delighted by the great response and enthusiasm we encountered from everyone who took part - thankyou very much who to all who attended!<br> | |
<br> | <br> | ||
</div> | </div> | ||
Line 752: | Line 755: | ||
</div> | </div> | ||
- | + | </div> | |
- | + | </div> | |
- | + | </div> | |
Latest revision as of 03:36, 18 October 2014